Abstract
Analytic “‘omic” techniques and systems biology driven bioinformatics have increasingly been a game changer in the study of herbal drugs, thanks to the simultaneous detection of entire molecular families in a given biological system, and the ability to collect, classify, network, and visualize a large number of analytical data through bioinformatics. The genomics area has been at the vanguard of this evolution. Other “‘omic” techniques, such as proteomics and metabonomics, are providing a fast-growing body of data both on biological targets and on phytocomplexes and their interactions. This has favored a more global view of biological processes, describing how perturbations can influence the steady state of a large number of the components of the system and their relations, changing the system as a whole. It is thus apparent that biological responses induced by phytocomplexes represent the net output of changes in the properties of a very large number of molecules, all acting in an interdependent fashion to form a highly connected network.
“‘Omic” techniques and systems biology are applied in herbal medicine at various levels, and provide novel strategies that can be exploited both for herbal drug research and medical use, in applications ranging from drug quality control to patient stratification. Network pharmaco-toxicology represents one of the most important applications of this new approach. Building up networks of molecular interactions between phytocomplex components and pharmaco-toxicological processes can provide a powerful predictive tool in herbal medicine. There is an increasing number of Web-based systems biology platforms, continuously fed with “'omics” data, providing a view of the complete biological system modulated by a given drug that can be used for predictive pharmacology and toxicology. Systems toxicology promises to be the best context for providing a mechanistic understanding of toxicological effects, thus allowing the prediction of responses to phytochemicals.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- ADME:
-
Adsorption, distribution, metabolism, excretion
- ADMET:
-
Adsorption, distribution, metabolism, excretion and toxicology
- AOP:
-
Adverse outcome pathway
- AST:
-
Addition and subtraction theory
- CMAP:
-
Connectivity map
- DCHD:
-
Da Chaihu decoction
- DILI:
-
Drug-induced liver injury
- FDA:
-
Food and Drug Administration
- HMDB:
-
Human metabolome database
- HMSP:
-
Herbal medicine systems pharmacology
- HS:
-
UK National Health System
- KEGG:
-
Kyoto Encyclopedia of Genes and Genomes
- LBVS:
-
Ligand-based virtual screening
- LINCS:
-
Library of integrated network-based cellular signatures
- MHD:
-
Ma-huang decoction
- MS:
-
Mass spectrometry
- NGS:
-
Next generation sequencing
- NIH:
-
(United States) National Institutes of Health
- NMR:
-
Nuclear magnetic resonance
- PEA:
-
Probability ensemble approach
- PGP:
-
Personal genome project
- PoT:
-
Pathways of toxicity
- PRM:
-
Parallel reaction monitoring
- QSARs:
-
Quantitative structure-activity relationships
- SBVS:
-
Structure-based virtual screening
- SNPs:
-
Single nucleotide polymorphisms
- SRM:
-
Selected reaction monitoring
- TCM:
-
Traditional Chinese medicine
- TCMSP:
-
Traditional Chinese medicine systems pharmacology database
- VS:
-
Virtual screening
- WES:
-
Whole exome sequencing
- XCHD:
-
Xiao Chaihu decoction
- WGS:
-
Whole genome sequencing
References
Afendi FM, Ono N, Nakamura Y et al (2013) Data mining methods for omics and knowledge of crude medicinal plants toward big data biology. Comput Struct Biotechnol J 4:e201301010. doi:10.5936/csbj.201301010
Ahn AC, Tewari M, Poon CS et al (2006) The clinical applications of a systems approach. PLoS Med 3:956–960
Altelaar AF, Munoz J, Heck AJ (2013) Next-generation proteomics: towards an integrative view of proteome dynamics. Nat Rev Genet 14:35–48. doi:10.1038/nrg3356
Bai JP, Fontana RJ, Price ND et al (2014) Systems pharmacology modeling: an approach to improving drug safety. Biopharm Drug Dispos 35:1–14. doi:10.1002/bdd.1871
Ball MP, Thakuria JV, Zaranek AW et al (2012) A public resource facilitating clinical use of genomes. Proc Natl Acad Sci USA 109:11920–11927. doi:10.1073/pnas.1201904109
Ball MP, Bobe JR, Chou MF et al (2014) Harvard personal genome project: lessons from participatory public research. Genome Med 6:10. doi:10.1186/gm527
Banerjeea S, Debnathb P, Kumar Debnathc P (2015) Ayurnutrigenomics: Ayurveda-inspired personalized nutrition from inception to evidence. J Tradit Complement Med. doi:10.1016/j.jtcme.2014.12.009
Barabàsi AL, Oltvai ZN (2004) Network biology: understanding the cell’s functional organization. Nat Rev Genet 5:101–113. doi:10.1038/nrg1272
Barabàsi AL, Gulbahce N, Loscalzo J (2011) Network medicine: a network-based approach to human disease. Nat Rev Genet 12:56–68. doi:10.1038/nrg2918
Barlow DJ, Buriani A, Ehrman T et al (2012) In-silico studies in Chinese herbal medicines’ research: evaluation of in-silico methodologies and phytochemical data sources, and a review of research to date. J Ethnopharmacol 140:526–534. doi:10.1016/j.jep.2012.01.041
Bouhifd M, Hartung T, Hogberg HT et al (2013) Toxicometabolomics. J Appl Toxicol 33:1365–1383. doi:10.1002/jat.2874
Bouhifd M, Hogberg HT, Kleensang A et al (2014) Mapping the human toxome by systems toxicology. Basic Clin Pharmacol Toxicol 115:24–31. doi:10.1111/bcpt.12198
Bredel M, Jacoby E (2004) Chemogenomics: an emerging strategy for rapid target and drug discovery. Nat Rev Genet 5:262–275. doi:10.1038/nrg1317
Brown JB, Okuno Y, Marcou G et al (2014) Computational chemogenomics: is it more than inductive transfer? J Comput Aided Mol Des 28:597–618. doi:10.1007/s10822-014-9743-1
Buriani A, Garcia-Bermejo ML, Bosisio E et al (2012) Omic techniques in systems biology approaches to traditional Chinese medicine research: present and future. J Ethnopharmacol 140:535–544. doi:10.1016/j.jep.2012.01.055
Butcher EC, Berg EL, Kunkel EJ (2004) Systems biology in drug discovery. Nat Biotechnol 22:1253–1259
Cao DS, Liang YZ, Deng Z et al (2013) Genome-scale screening of drug-target associations relevant to Ki using a chemogenomics approach. PLoS One 8:e57680. doi:10.1371/journal.pone.0057680
Carrascosa MC, Massaguer OL, Mestres J (2012) PharmaTrek: a semantic Web explorer for open innovation in multitarget drug discovery. Mol Inform 31:537–541. doi:10.1002/minf.201200070
Chen YC, Douville C, Wang C et al (2014) A probabilistic model to predict clinical phenotypic traits from genome sequencing. PLoS Comput Biol 10:e1003825. doi:10.1371/journal.pcbi.1003825
Chen S, Song J, Sun C et al (2015a) Herbal genomics: examining the biology of traditional medicines. Science 347:S27–S29
Chen T, Zhao J, Ma J et al (2015b) Web resources for mass spectrometry-based proteomics. Genomics Proteomics Bioinforma 13:36–39. doi:10.1016/j.gpb.2015.01.004
Chupakhin V, Marcou G, Gaspar H et al (2014) Simple ligand-receptor interaction descriptor (SILIRID) for alignment-free binding site comparison. Comput Struct Biotechnol J 10:33–37. doi:10.1016/j.csbj.2014.05.004
Clayton TA, Lindon JC, Cloarec O et al (2006) Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature 440:1073–1077
Crosetto N, Bienko M, van Oudenaarden A (2015) Spatially resolved transcriptomics and beyond. Nat Rev Genet 16:57–66. doi:10.1038/nrg3832
Csermely P, Korcsmáros T, Kiss HJ (2013) Structure and dynamics of molecular networks: a novel paradigm of drug discovery a comprehensive review. Pharmacol Ther 138:333–408. doi:10.1016/j.pharmthera.2013.01.016
D’Argenio V, Salvatore F (2015) The role of the gut microbiome in the healthy adult status. Clin Chim Acta. doi:10.1016/j.cca.2015.01.003
Deloukas P, Kanoni S, Willenborg C et al (2013) Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet 45:25–33. doi:10.1038/ng.2480
Dewey FE, Grove ME, Pan C et al (2014) Clinical interpretation and implications of whole-genome sequencing. JAMA 311:1035–1045. doi:10.1001/jama.2014.1717
Ding F, Zhang Q, Ung COL et al (2015) An analysis of chemical ingredients network of Chinese herbal formulae for the treatment of coronary heart disease. PLoS One 10:e0116441. doi:10.1371/journal.pone.0116441
Drabovicha AP, Martínez-Morilloa E, Diamandisa EP (2015) Toward an integrated pipeline for protein biomarker development. Biochim Biophys Acta 1854:677–686. doi:10.1016/j.bbapap.2014.09.006
Duerr RH, Taylor KD, Brant SR et al (2006) Genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314:1461–1463. doi:10.1126/science.1135245
Efferth T, Koch E (2011) Complex interactions between phytochemicals. The multi-target therapeutic concept of phytotherapy. Curr Drug Targets 12:122–123. doi:10.2174/138945011793591626
Ekins S, Nikolsky Y, Nikolskaya T (2005) Techniques: application of systems biology to absorption, distribution, metabolism, excretion, and toxicity. Trends Pharmacol Sci 26:202–209
Elrakaiby M, Dutilh BE, Rizkallah MR et al (2014) Pharmacomicrobiomics: the impact of human microbiome variations on systems pharmacology and personalized therapeutics. OMICS 18:402–414. doi:10.1089/omi.2014.0018
Fauzi FM, Koutsoukas A, Lowe R et al (2013) Chemogenomics approach to razionalizing the mode-of-action of traditional Chinese and Ayurvedic medicines. J Chem Inf Model 53:661–673. doi:10.1021/ci3005513
Fayaz SM, Suvanish Kumar VS, Rajanikant KG (2014) Finding needles in a haystack: application of network analysis and target enrichment studies for the identification of potential anti-diabetic phytochemicals. PLoS One 9:e112911. doi:10.1371/journal.pone.0112911
Franke A, McGoven DPB, Barrett JC et al (2010) Genome-wide meta-analysis increases to 71 the number of confirmed Crohn’s disease susceptibility loci. Nat Genet 42:1118–1125. doi:10.1038/ng.717
Gao Y, Holland RD, Yu LR (2009) Quantitative proteomics for drug toxicity. Brief Func Genom Proteomic 8:158–166. doi:10.1093/bfgp/elp006
Ghosh S, Matsuoka Y, Asai Y et al (2011) Software for systems biology: from tools to integrated platforms. Nat Rev Genet 12:821–832. doi:10.1038/nrg3096
Gika HG, Wilson ID, Theodoridis GA (2014) LC-MS-based holistic metabolic profiling. Problems, limitations, advantages, and future perspectives. J Chromatogr B Anal Technol Biomed Life Sci 966:1–6. doi:10.1016/j.jchromb.2014.01.054
Glusman G, Severson A, Dhankani V et al (2015) Identification of copy number variants in whole-genome data using reference coverage profiles. Front Genet 6:45. doi:10.3389/fgene.2015.00045
Gong J, Cai C, Liu X et al (2013) ChemMapper: a versatile web server for exploring pharmacology and chemical structure association based on molecular 3D similarity method. Bioinformatics 29:1827–1829. doi:10.1093/bioinformatics/btt270
Gonzalez-Garay ML, McGuire AL, Pereira S et al (2013) Personalized genomic disease risk of volunteers. Proc Natl Acad Sci USA 110:16957–16962. doi:10.1073/pnas.1315934110
Gu P, Chen H (2014) Modern bioinformatics meets traditional Chinese medicine. Brief Bioinform 15:984–1003. doi:10.1093/bib/bbt063
Guo L, Du Y, Chang S et al (2014) rSNPBase: a database for curated regulatory SNPs. Nucleic Acids Res 42(Database issue):D1033–D1039. doi:10.1093/nar/gkt1167
Guo DA, Wu WY, Ye M et al (2015a) A holistic approach to the quality control of traditional Chinese medicines. Science 347:S29–S31
Guo Z, Zhang Y, Zou L et al (2015b) A proteomic analysis of individual and gender variations in normal human urine and cerebrospinal fluid using iTRAQ quantification. PLoS One 10:e0133270. doi:10.1371/journal.pone.0133270
Gupta-Ostermann D, Bajorath J (2014) The ‘SAR Matrix’ method and its extensions for applications in medicinal chemistry and chemogenomics. Version 2 F1000Res 3:113. doi:10.12688/f1000research.4185.2
Haiman CA, Chen GK, Vachon CM et al (2011) A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet 43:1210–1214. doi:10.1038/ng.985
Hamon J, Jennings P, Bois FY (2014) Systems biology modeling of omics data: effect of cyclosporine a on the Nrf2 pathway in human renal cells. BMC Syst Biol 8:76. doi:10.1186/1752-0509-8-76
Harvey AL, Edrada-Ebel R, Quinn RJ (2015) The re-emergence of natural products for drug discovery in the genomics era. Nat Rev Drug Discov 14:111–129. doi:10.1038/nrd4510
Heather JM, Chain B (2015) The sequence of sequencers: the history of sequencing DNA. Genomics 10:1–8. doi:10.1016/j.ygeno.2015.11.003
Hood L, Heath JR, Phelps ME et al (2004) Systems biology and new technologies enable predictive and preventative medicine. Science 306:640–643
Howell BA, Yang Y, Kumar R et al (2012) In vitro to in vivo extrapolation and species response comparisons for drug-induced liver injury (DILI) using DILIsym: a mechanistic, mathematical model of DILI. J Pharmacokinet Pharmacodyn 39:527–541. doi:10.1007/s10928-012-9266-0
Huang C, Zheng C, Li Y et al (2014) Systems pharmacology in drug discovery and therapeutic insight for herbal medicines. Brief Bioinform 15:710–733. doi:10.1093/bib/bbt035
Ideker T, Galitsky T, Hood L (2001) A new approach to decoding life: systems biology. Annu Rev Genomics Hum Genet 2:343–372
Ilatovskiy AV, Abagyan R, Kufareva I (2013) Quantum mechanics approaches to drug research in the era of structural chemogenomics. Int J Quantum Chem 113:1669–1675. doi:10.1002/qua.24400
James LP (2013) Metabolomics: integration of a new “Omics” with clinical pharmacology. Clin Pharmacol Ther 94:547–551. doi:10.1038/clpt.2013.166
Ji B, Nielsen J (2015) New insight into the gut microbiome through metagenomics. Adv Genomics Genet 2015–5:77–91. doi:10.2147/AGG.S57215
Jia WH, Zhang B, Matsuo K et al (2013) Genome-wide association analysis in East Asians identify new susceptibility loci for colorectal cancer. Nat Genet 45:191–196. doi:10.1038/ng.2505
Jiang X, Lv B, Li P et al (2015) Bioactivity-integrated UPLC/Q-TOF-MS of Danhong injection to identify NF-kB inhibitors and anti-inflammatory targets based on endothelial cell culture and network pharmacology. J Ethnopharmacol 174:270–276. doi:10.1016/j.jep.2015.08.026
Jirtle RL, Skinner MK (2007) Environmental epigenomics and disease susceptibility. Nat Rev Genet 8:253–262
Joyce AR, Pallson BØ (2006) The model organism as a system: integrating “omics” data sets. Nat Rev Mol Cell Biol 7:198–210
Kell DB, Goodacre R (2014) Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery. Drug Discov Today 19:171–182. doi:10.1016/j.drudis.2013.07.014
Kinoshita E, Kinoshita-Kikuta E, Koike T (2015) Advances in Phos-tag-based methodologies for separation and detection of the phosphoproteome. Biochim Biophys Acta 1854:601–608. doi:10.1016/j.bbapap.2014.10.004
Kitano H (2002) Computational systems biology. Nature 420:206–210. doi:10.1038/nature1254
Klabunde T (2007) Chemogenomic approaches to drug discovery: similar receptors bind similar ligands. Br J Pharmacol 152:5–7. doi:10.1038/sj.bjp.0707308
Kleensang A, Maertens A, Rosenberg M et al (2014) t4 workshop report: pathways of toxicity. ALTEX 31:53–61. doi:10.14573/altex.1309261
Knudsen TB, Keller DA, Sander M et al (2015) FutureTox II: in vitro data and in silico models for predictive toxicology. Toxicol Sci 143:256–267. doi:10.1093/toxsci/kfu234
Kongsbak K, Hadrup N, Audouze K et al (2014) Applicability of computational systems biology in toxicology. Basic Clin Pharmacol Toxicol 115:45–49. doi:10.1111/bcpt.12216
Kouskoumvekaki I, Panagiotou G (2011) Navigating the human metabolome for biomarker identification and design of pharmaceutical molecules. J Biomed Biotechnol. doi:10.1155/2011/525497
Kwok CK, Tang Y, Assmann SM et al (2015) The RNA structurome: transcriptome-wide structure probing with next-generation sequencing. Trends Biochem Sci 40:221–232. doi:10.1016/j.tibs.2015.02.005
Lan Q, Hsiung CA, Matsuo K et al (2012) Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia. Nat Genet 44:1330–1335. doi:10.1038/ng.2456
Lao Y, Wang X, Xu N et al (2014) Application of proteomics to determine the mechanism of action of traditional Chinese medicine. remedies. J Ethnopharmacol 155:1–8. doi:10.1016/j.jep.2014.05.022
Lavecchia A, Di Giovanni C (2013) Virtual screening strategies in drug discovery: a critical review. Curr Med Chem 20:2839–2860. doi:10.2174/09298673113209990001
Li S, Zhang B (2013) Traditional Chinese medicine network pharmacology: theory, methodology and application. Chin J Nat Med 11:110–120. doi:10.1016/S1875-5364(13)60037-0
Li F, Lu J, Ma X (2011) Profiling the reactive metabolites of xenobiotics using metabolomic technologies. Chem Res Toxicol 24:744–751. doi:10.1021/tx200033v
Li B, Tao W, Zheng C et al (2014) Systems pharmacology-based approach for dissecting the addition and subtraction theory of traditional Chinese medicine: an example using Xiao-Chaihu-Decoction and Da-Chaihu-Decoction. Comput Biol Med 53:19–29. doi:10.1016/j.compbiomed.2014.05.007
Li B, Zhang Y, Yu Y et al (2015a) Quantitative assessment of gene expression network module-validation methods. Sci Rep 5:15258. doi:10.1038/srep15258
Li J, Zhao P, Li Y et al (2015b) Systems pharmacology-based dissection of mechanisms of Chinese medicinal formula Bufei Yishen as an effective treatment for chronic obstructive pulmonary disease. Sci Rep 5:15290. doi:10.1038/srep15290
Li P, Huang C, Fu Y et al (2015c) Large-scale exploration and analysis of drug combinations. Bioinformatics. doi:10.1093/bioinformatics/btv080
Li Y, Zhang J, Zhang L et al (2015d) Systems pharmacology to decipher the combinational anti-migraine effects of Tianshu formula. J Ethnopharmacol 174:45–56. doi:10.1016/j.jep.2015.07.043
Liu ET (2009) Integrative biology – a strategy for systems biomedicine. Nat Rev Genet 10:64–68
Lord PG, Nie A, McMillian M (2006) Application of genomics in preclinical drug safety evaluation. Basic Clin Pharmacol Toxicol 98:537–546
Ma YM, Zhang XZ, Su ZZ et al (2015) Insight into the molecular mechanism of a herbal injection by integrating network pharmacology and in vitro. J Ethnopharmacol 173:91–99. doi:10.1016/j.jep.2015.07.016
Ma’ayan A (2011) Introduction to network analysis in systems biology. Sci Signal 4:tr5. doi:10.1126/scisignal.2001965
Manolio TA, Collins FS (2009) The HapMap and genome-wide association studies in diagnosis and therapy. Annu Rev Med 60:443–456. doi:10.1146/annurev.med.60.061907.093117
Manyam G, Birerdinc A, Baranova A (2015) KPP: KEGG pathway painter. BMC Syst Biol 9:S3. doi:10.1186/1752-0509-9-S2-S3
Martínez V, Navarro C, Cano C et al (2014) DrugNet: network-based drug-disease prioritization by integrating heterogeneous data. Artif Intell Med 63:41–49. doi:10.1016/j.artmed.2014.11.003
Medina-Franco JL, Giulianotti MA, Welmaker GS et al (2013) Shifting from the single- to the multitarget paradigm in drug discovery. Drug Discov Today 18:495–501. doi:10.1016/j.drudis.2013.01.008
Medina-Franco JL, Méndez-Lucio O, Martinez-Mayorga K (2014) The interplay between molecular modeling and chemoinformatics to characterize protein-ligand and protein-protein interactions landscapes for drug discovery. Adv Protein Chem Struct Biol 96:1–37. doi:10.1016/bs.apcsb.2014.06.001
Miller GW, Jones DP (2014) The nature of nurture: refining the definition of the exposome. Toxicol Sci 137:1–2. doi:10.1093/toxsci/kft251
Mitra K, Carvunis AR, Ramesh SK et al (2013) Integrative approaches for finding modular structure in biological networks. Nat Rev Genet 14:719–732. doi:10.1038/nrg3552
Morris MK, Chi A, Melas IN et al (2014) Phosphoproteomics in drug discovery. Drug Discov Today 19:425–432. doi:10.1016/j.drudis.2013.10.010
Nantasenamat C, Prachayasittikul V (2015) Maximizing computational tools for successful drug discovery. Expert Opin Drug Discov 10:321–329. doi:10.1517/17460441.2015.1016497
Nicholson JK, Lindon JC (2008) Systems biology: metabonomics. Nature 455:1054–1056. doi:10.1038/4551054a
Nicholson JK, Wilson ID (2003) Understanding “global” systems biology: metabonomics and the continuum of metabolism. Nat Rev Drug Discov 2:668–676
Ouedraogo M1, Baudoux T, Stévigny C et al (2012) Review of current and “omics” methods for assessing the toxicity (genotoxicity, teratogenicity and nephrotoxicity) of herbal medicines and mushrooms. J Ethnopharmacol 140:492–512. doi:10.1016/j.jep.2012.01.059
Palotie A, Widén E, Ripatti S (2013) From genetic discovery to future personalized health research. New Biotechnol 30:291–295
Paricharak S, Cortés-Ciriano I, IJzerman AP et al (2015) Proteochemometric modelling coupled to in silico target prediction: an integrated approach for the simultaneous prediction of polypharmacology and binding affinity/potency of small molecules. J Cheminform 15:7–15. doi:10.1186/s13321-015-0063-9
Pelkonen O (2010) Predictive toxicity: grand challenges. Front Pharmacol 1:3. doi:10.3389/fphar.2010.00003
Pelkonen O, Tolonen A, Korjamo T et al (2009) From known knowns to known unknowns: predicting in vivo drug metabolites. Bioanalysis 1:393–414. doi:10.4155/bio.09.32
Pelkonen O, Turpeinen M, Raunio H (2011) In vivo-in vitro-in silico pharmacokinetic modelling in drug development: current status and future directions. Clin Pharmacokinet 50:483–491. doi:10.2165/11592400-000000000-00000
Pelkonen O, Pasanen M, Lindon JC et al (2012) Omics and its potential impact on R&D and regulation of complex herbal products. J Ethnopharmacol 140:587–593. doi:10.1016/j.jep.2012.01.035
Pennisi E (2007) Metagenomics massive microbial sequence project proposed. Science 315:1781
Peterson AC, Russell JD, Bailey DJ et al (2012) Parallell reaction monitoring for high resolution and high mass accuracy quantitative, targeted proteomics. Moll Cell Proteomics 11:1475–1488. doi:10.1074/mcp.O112.020131
Picotti P, Aebersold R (2012) Selected reaction monitoring–based proteomics: workflows, potential, pitfalls and future directions. Nat Methods 9:555–566. doi:10.1038/nmeth.2015
Posma JM, Robinette SL, Holmes E et al (2014) Metabonetworks, an interactive Matlab-based toolbox for creating, customizing and exploring subnetworks from KEGG. Bioinformatics 30:893–895. doi:10.1093/bioinformatics/btt612
Ramirez T, Daneshian M, Kamp H et al (2013) Metabolomics in toxicology and preclinical research. ALTEX 30:209–225
Ravindranath AC, Perualila-Tan N, Kasim A et al (2015) Connecting gene expression data from connectivity map and in silico target predictions for small molecule mechanism-of-action analysis. Mol Biosyst 11:86–96. doi:10.1039/c4mb00328d
Robertson DG (2005) Metabonomics in toxicology: a review. Toxicol Sci 85:809–822. doi:10.1093/toxsci/kfi102
Rognan D (2007) Chemogenomic approaches to rational drug design. Br J Pharmacol 152:38–52. doi:10.1038/sj.bjp.0707307
Rouquié D, Heneweer M, Botham J et al (2015) Contribution of new technologies to characterization and prediction of adverse effects. Crit Rev Toxicol 45:172–183. doi:10.3109/10408444.2014.986054
Ru J, Li P, Wang J et al (2014) TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform 6:13. doi:10.1186/1758-2946-6-13
Scalbert A, Brennan L, Manach C et al (2014) The food metabolome: a window over dietary exposure. Am J Clin Nutr 99:1286–1308. doi:10.3945/ajcn.113.076133
Shen Y, Rahman M, Piccolo SR et al (2015) ASSIGN: context-specific genomic profiling of multiple heterogeneous biological pathways. Bioinformatics 31:1745–1753. doi:10.1093/bioinformatics/btv031
Shi Y, Hu Z, Wu C et al (2011) A genome-wide association study identifies new susceptibility loci for non-cardia gastric cancer at 3q13.31 and 5p13.1. Nat Genet 43:1215–1218. doi:10.1038/ng.978
Siva N (2015) UK gears up to decode 100,000 genomes from NHS patients. Lancet 385:103–104. doi:10.1016/S0140-6736(14)62453-3
Smith TD, Vihinen M, on Behalf of the Human Variome Project (2015) Standard development at the Human Variome Project. Database. doi:10.1093/database/bav024, pii: bav024
Sturla SJ, Boobis AR, FitzGerald RE et al (2014) Systems toxicology: from basic research to risk assessment. Chem Res Toxicol 27:314–329. doi:10.1021/tx400410s
Taboureau O, Hersey A, Audouze K et al (2012) Toxicogenomics investigation under the eTOX project. J Pharmacogenomics Pharmacoproteomics S7:001. doi:10.4172/2153-0645.S7-001
The Wellcome Trust Case Control Consortium (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447:661–678. doi:10.1038/nature05911
Thomas G, Jacobs KB, Yeager M et al (2008) Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet 40:310–315. doi:10.1038/ng.91
Titz B, Elamin A, Martin F et al (2014) Proteomics for systems toxicology. Comput Struct Biotechnol J 11:73–90. doi:10.1016/j.csbj.2014.08.004
Toga AW, Foster I, Kesselman C et al (2015) Big biomedical data as the key resource for discovery science. J Am Med Inform Assoc 22:1126–1131. doi:10.1093/jamia/ocv077
Turnbaugh PJ, Ley RE, Hamady M et al (2007) The human microbiome project. Nature 449:804–810
Uhlén M, Fagerberg L, Hallström BM et al (2015) Tissue-based map of the human proteome. Science 347:6220. doi:10.1126/science.1260419
Van den Hof WF, Ruiz-Aracama A, Van Summeren A et al (2015) Integrating multiple 'omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro 29:489–501. doi:10.1016/j.tiv.2014.12.016
Voight BF, Scott LJ, Steinthorsdottir V et al (2010) Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 42:579–589. doi:10.1038/ng.609
Wang L, Xie XQ (2014) Computational target fishing: what should chemogenomics researchers expect for the future of in silico drug design and discovery? Future Med Chem 6:247–249. doi:10.4155/fmc.14.5
Wang K, Lee I, Carlson G et al (2010) Systems biology and the discovery of diagnostic biomarkers. Dis Markers 28:199–207. doi:10.3233/DMA-2010-0697
Wang S, Tong Y, Ng TB et al (2015) Network pharmacological identification of active compounds and potential actions of Erxian decoction in alleviating menopause-related symptoms. Chin Med 10:19. doi:10.1186/s13020-015-0051-z
Wen Z, Wang Z, Wang S et al (2011) Discovery of molecular mechanisms of traditional Chinese medicinal formula Si-Wu-Tang using gene expression microarray and connectivity map. PLoS One 6:e18278. doi:10.1371/journal.pone.0018278
Wen W, Cho YS, Zheng W et al (2012) Meta-analysis identifies common variants associated with body mass index in East Asians. Nat Genet 44:307–311. doi:10.1038/ng.1087
Wishart D, Arndt D, Pon A et al (2015) T3DB: the toxic exposome database. Nucleic Acids Res 43:D928–D934. doi:10.1093/nar/gku1004
Xu Q, Qu F, Pelkonen O (2012) Network pharmacology and traditional Chinese medicine In: Sakagami H (ed) Alternative medicine, Intech, (ISBN:978-953-51-0903-7), pp 277–297. doi.org/10.5772/53868
Yao Y, Zhang X, Wang Z et al (2013) Deciphering the combination principles of traditional Chinese medicine from a systems pharmacology perspective based on Ma-huang decoction. J Ethnopharmacol 150:619–638. doi:10.1016/j.jep.2013.09.018
Zanetti KA, Mette E, Maruvada P et al (2014) The future of metabolomic profiling in population-based research: opportunities and challenges. J Anal Bioanal Tech 5:203. doi:10.4172/2155-9872
Zeng P, Zhao Y, Qian C et al (2015) Statistical analysis for genome-wide association study. J Biomed Res 29:285–297. doi:10.7555/JBR.29.20140007
Zhang JD, Berntenis N, Roth A et al (2014) Data mining reveals a network of early-response genes as a consensus signature of drug-induced in vitro and in vivo toxicity. Pharmacogenomics J 14:208–216. doi:10.1038/tpj.2013.39
Zhang A, Sun H, Yan G et al (2015a) Metabolomics for biomarker discovery: moving to the clinic. Biomed Res Int 2015:354671. doi:10.1155/2015/354671
Zhang J, Li Y, Chen SS et al (2015b) Systems pharmacology dissection of the anti-inflammatory mechanism for the medicinal herb Folium eriobotryae. Int J Mol Sci 16:2913–2941. doi:10.3390/ijms16022913
Zhao F, Li G, Yang Y et al (2015a) A network pharmacology approach to determine active ingredients and rationality of herb combinations of Modified-Simiaowan for treatment of gout. J Ethnopharmacol 168:1–16. doi:10.1016/j.jep.2015.03.035
Zhao X, Zheng X, Fan TP et al (2015b) A novel drug discovery strategy inspired by traditional medicine philosophies. Science 347:S38–S40
Zheng CS, Fu CL, Pan CB et al (2015) Deciphering the underlying mechanism of Diesun Miaofang in traumatic injury from systems pharmacology perspective. Mol Med Rep 12:1769–1776. doi:10.3892/mmr.2015.3638
Zhou W, Wang Y (2013) A network-based analysis of the types of coronary artery disease from traditional Chinese medicine perspective: potential for therapeutics and drug discovery. J Ethnopharmacol 151:66–77. doi:10.1016/j.jep.2013.11.007
Zou D, Ma L, Yu J et al (2015) Biological databases for human research. Genomics Proteomics Bioinforma 13:55–63. doi:10.1016/j.gpb.2015.01.006
Acknowledgements
We would like to thank Roberta Sato at the Library of the Department of Pharmaceutical and Pharmacological Sciences of the University of Padova for her technical assistance with database search and bibliography, and Mariagnese Barbera for text revision.
Conflict of Interest
Alessandro Buriani and Stefano Fortinguerra are in charge of the Personalized Medicine service of the Gruppo Data Medica Padova.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Buriani, A., Fortinguerra, S., Carrara, M., Pelkonen, O. (2017). Systems Network Pharmaco-Toxicology in the Study of Herbal Medicines. In: Pelkonen, O., Duez, P., Vuorela, P., Vuorela, H. (eds) Toxicology of Herbal Products. Springer, Cham. https://doi.org/10.1007/978-3-319-43806-1_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-43806-1_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-43804-7
Online ISBN: 978-3-319-43806-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)